de

Registrieren
Investieren birgt Risiken und ist nicht für alle Anleger geeignet.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Aktien・BioCryst Pharmaceuticals Inc
Search

BioCryst Pharmaceuticals Inc

Geschlossen

Branche Gesundheitswesen

7.99 -1.11

Starkes Kaufsignal

Kursupdate 6. Sept. 2024, 19:57 UTC

BuySell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.98

Max

8.05

Schlüsselkennzahlen

By Trading Economics

EPS

-0.172

Gewinnspanne

-66.092

Angestellte

536

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+92.11 upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Okt. 2024

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

41M

990M

Vorheriger Eröffnungskurs

9.1

Vorheriger Schlusskurs

7.99

Nachrichtenstimmung

By Acuity

67%

33%

308 / 365 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

6.1 / 7.65 Unterstützung & Widerstand

BioCryst Pharmaceuticals Inc Chart

Ähnliche Nachrichten

6. Sept. 2024, 22:41 UTC

Market Talk

KinderCare and StandardAero File for IPOs -- Market Talk

DJ

Lesen

6. Sept. 2024, 21:18 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

DJ

Lesen

6. Sept. 2024, 21:05 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

DJ

Lesen

6. Sept. 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 20:39 UTC

Ergebnisse

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

DJ

Lesen

6. Sept. 2024, 20:35 UTC

Top News

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

DJ

Lesen

6. Sept. 2024, 20:34 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

DJ

Lesen

6. Sept. 2024, 20:11 UTC

Top News

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

DJ

Lesen

6. Sept. 2024, 19:51 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

DJ

Lesen

6. Sept. 2024, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Hold Gains -- Market Talk

DJ

Lesen

6. Sept. 2024, 19:14 UTC

Market Talk

Oil Futures Extend Losses on Demand Concerns -- Market Talk

DJ

Lesen

6. Sept. 2024, 19:01 UTC

Market Talk

Gold Slips on Prevailing Uncertainty -- Market Talk

DJ

Lesen

6. Sept. 2024, 18:27 UTC

Top News

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

DJ

Lesen

6. Sept. 2024, 18:25 UTC

Market Talk

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

DJ

Lesen

6. Sept. 2024, 18:15 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

DJ

Lesen

6. Sept. 2024, 18:12 UTC

Top News

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

DJ

Lesen

6. Sept. 2024, 17:44 UTC

Market Talk

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

DJ

Lesen

6. Sept. 2024, 17:30 UTC

Market Talk

U.S Oil Rig Count Unchanged at 483 -- Market Talk

DJ

Lesen

6. Sept. 2024, 17:30 UTC

Top News

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

DJ

Lesen

6. Sept. 2024, 17:27 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

DJ

Lesen

6. Sept. 2024, 17:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 17:00 UTC

Market Talk

Mexican Inflation Seen Easing in August -- Market Talk

DJ

Lesen

6. Sept. 2024, 16:36 UTC

Market Talk

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

DJ

Lesen

6. Sept. 2024, 16:35 UTC

Ergebnisse
Heiße Aktien

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

DJ

Lesen

6. Sept. 2024, 16:33 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Ergebnisse

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

DJ

Lesen

Peer-Vergleich

Kursveränderung

BioCryst Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

92.11% Vorteil

12-Monats-Prognose

Durchschnitt 15.33 USD  92.11%

Hoch 30 USD

Tief 7 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für BioCryst Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

9 ratings

8

Buy

1

Halten

0

Sell

Basierend auf 9 Analysten, die in den letzten 3 Monaten Aktienbewertungen für BioCryst Pharmaceuticals Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

6.1 / 7.65Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Recent bullish events outweigh bearish events.

Mittelfristig

Strong Bullish Evidence

All events are bullish.

Langfristig

Strong Bearish Evidence

All events are bearish.

Stimmung

By Acuity

308 / 365 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc. discovers oral and small-molecule medicines that treat rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an oral, once-daily therapy that is approved in the United States, the European Union, Japan, and the United Kingdom for the prevention of hereditary angioedema attacks in adults and pediatric patients 12 years and older. The Company has several ongoing development programs, including BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an activin receptor-like kinase-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, an antiviral drug for Marburg virus disease and Yellow Fever. RAPIVAB (peramivir injection) is a viral neuraminidase inhibitor for the treatment of influenza, has received regulatory approval in the United States, Canada, Australia, Japan, Taiwan and Korea.

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%